Prognostic value of reduction in left atrial size during a follow-up of heart failure: an observational study

Masayuki Shiba1, Takao Kato2, Takeshi Morimoto3

  • 1Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

BMJ Open
|February 20, 2021
PubMed

Insights

Reducing left atrial diameter (LAD) after acute decompensated heart failure (ADHF) hospitalization is linked to better prognosis. This finding suggests LAD changes are a useful echocardiographic marker for heart failure patients.

Area of Science:

  • Cardiology
  • Echocardiography
  • Heart Failure Research

Background:

  • The prognostic significance of sequential changes in left atrial diameter (LAD) in heart failure (HF) patients is not well understood.
  • Left atrial remodeling is a known indicator of cardiovascular disease severity and prognosis.

Purpose of the Study:

  • To investigate the association between reduction in LAD and clinical outcomes in patients with HF.
  • To determine if LAD changes can serve as a prognostic marker in HF management.

Main Methods:

  • A multicenter prospective cohort study involving 673 patients with HF from the Kyoto Congestive Heart Failure registry.
  • Patients were categorized into two groups based on LAD change from baseline to 6-month follow-up echocardiography: LAD reduction (<0 mm) and no LAD reduction (≥0 mm).
  • The primary outcome was a composite of all-cause death or HF hospitalization within 180 days post-follow-up echocardiography.

Main Results:

  • A significantly lower 180-day incidence of the primary composite outcome was observed in the LAD reduction group (13.3%) compared to the no-reduction group (22.2%, p=0.002).
  • Adjusted analysis, controlling for 15 confounders, confirmed that LAD reduction remained a significant predictor of a lower risk for the primary outcome (HR 0.59, 95% CI 0.36 to 0.97, p=0.04).

Conclusions:

  • Reduction in LAD during follow-up after acute decompensated heart failure hospitalization is associated with a reduced risk of all-cause death or HF hospitalization.
  • Changes in LAD represent a potentially simple and valuable echocardiographic marker for monitoring HF prognosis.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
210
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
173
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
85